Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Merck & Company (MRK)

Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the first being declining sales of COVID products, Comirnaty and Paxlovid. In 2025,...

JNJ : 152.19 (+0.57%)
MRK : 80.32 (+0.20%)
LLY : 778.08 (+0.97%)
PFE : 24.31 (+1.17%)
Sanofi Trades Below 50 & 200-Day Moving Averages: Time to Buy the Dip?

Sanofi’s SNY stock has been trading below its 200-day and 50-day moving averages since early June. On June 23, the stock’s closing price of $48.18 was below its 50-day moving average of $50.32 and...

AZN : 70.54 (-0.14%)
MRK : 80.32 (+0.20%)
REGN : 522.27 (+2.02%)
SNY : 48.42 (+0.50%)
EXEL Stock Rises on Positive Data From Colorectal Cancer Study

Shares of Exelixis, Inc. EXEL gained 7.4% on June 23, after the company announced positive top-line results from the late-stage STELLAR-303 study.This phase III study is a global, multicenter, randomized,...

MRK : 80.32 (+0.20%)
EXEL : 45.72 (+5.42%)
BMY : 47.03 (+0.23%)
Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth?

AbbVie ABBV has built a substantial oncology franchise. Initially anchored by blood cancer drugs Imbruvica and Venclexta, the company has also been expanding its offerings into solid tumors. Its latest...

AZN : 70.54 (-0.14%)
MRK : 80.32 (+0.20%)
ABBV : 185.55 (+0.97%)
PFE : 24.31 (+1.17%)
Should You Buy Caris Life Sciences Stock After the CAI IPO?

Shares of the company are up almost 30% from its IPO price.

MRK : 80.32 (+0.20%)
CAI : 27.70 (+6.78%)
ABBV : 185.55 (+0.97%)
Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?

Pfizer PFE is one of the largest and most successful drugmakers in oncology. It boasts a strong portfolio of approved cancer medicines as well as a robust pipeline of cancer candidates with a focus on...

AZN : 70.54 (-0.14%)
MRK : 80.32 (+0.20%)
PFE : 24.31 (+1.17%)
BMY : 47.03 (+0.23%)
Stocks Slightly Higher as Bond Yields Decline

The S&P 500 Index ($SPX ) (SPY ) today is up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. June E-mini S&P futures (ESM25...

$SPX : 6,092.18 (+1.11%)
JPM : 281.26 (+1.07%)
ADI : 234.98 (+1.73%)
MRK : 80.32 (+0.20%)
ORCL : 215.27 (+3.98%)
$IUXX : 22,190.52 (+1.53%)
NQU25 : 22,393.75 (-0.08%)
AMGN : 277.49 (+1.85%)
BMY : 47.03 (+0.23%)
QQQ : 539.78 (+1.53%)
ZNU25 : 111-190 (-0.06%)
ESU25 : 6,140.50 (-0.09%)
2 Option Ideas to Consider this Wednesday for Bearish Traders

Today, we are using some moving average filters to find bullish stocks and then looking at a couple of different trade ideas.

MRK : 80.32 (+0.20%)
ADBE : 382.34 (+0.58%)
2 Dividend Stocks to Buy and Never Sell

JNJ : 152.19 (+0.57%)
MRK : 80.32 (+0.20%)
SMMT : 20.92 (+2.60%)
KVUE : 21.19 (-0.84%)
Stocks Tumble and Oil Surges on Middle East Jitters

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.84%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.00%. June E-mini...

UAL : 79.02 (+2.66%)
MPC : 165.29 (-0.79%)
DHI : 129.63 (+0.75%)
CVX : 143.55 (-2.25%)
MRK : 80.32 (+0.20%)
LVS : 42.63 (+1.62%)
$IUXX : 22,190.52 (+1.53%)
ALKS : 29.35 (+0.31%)
PFE : 24.31 (+1.17%)
ZNU25 : 111-190 (-0.06%)
OXY : 42.48 (-3.34%)
ESU25 : 6,140.50 (-0.09%)

Barchart Exclusives

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here?
Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for the second half of 2025 as well. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar